person
as of 2026-07-01Xiaoduo Fan, MD, MPH, MS
Xiaoduo FanXiaoduo Fan, MDXiaoduo Fan, MD, MPH
at a glance
Roles: Principal Investigator, Author
KOL signal score 9
1 publications · 1 high-value
Cross-drug reach: 1 competitor drugs
Synthesized from structured facts only — each point cited above.
Profile
Affiliation
University of Massachusetts, Worcester
Roles
Principal Investigator, Author
KOL signal
9
Publications
1 (1 high-value)
Trial investigator
yes
Publishes on
1 drugs
Trials led
9
Telmisartan Pilot Study on Treatment Resistant Schizophrenia
NCT03868839Phase 2Terminated
Salsalate as an Adjunctive Treatment for Patients With Schizophrenia
NCT01578486Phase 4Completed
Effect of Single Dose Intranasal Insulin On Cognitive Function
NCT00646581Phase 4Completed
Intranasal Insulin Treatment in Patients With Schizophrenia
NCT00575666Phase 4Completed
Exenatide Weekly Injections as an Adjunctive Treatment in Patients With Schizophrenia
NCT02417142Phase 4Completed
Controlled Trial of Brexpiprazole For The Treatment of Co-occurring Schizophrenia and Substance Use Disorder
NCT03526354Phase 4Completed
Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia
NCT06174116Phase 4Recruiting
L-arginine Study for Persistent Symptoms of Schizophrenia
NCT04054973Phase 2Withdrawn
Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With Schizophrenia
NCT00981526Phase 4Completed
Publications & congress
1
Brexpiprazole for the Treatment of Co-occurring Schizophrenia and Substance Use Disorder: A Multisite, Randomized, Controlled Trial.
The Journal of clinical psychiatry · 2025 · high-value
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
publishes on
PRINCIPAL_INVESTIGATOR